CN111658703A - Traditional Chinese medicine for accelerating recovery of pneumonia patients - Google Patents

Traditional Chinese medicine for accelerating recovery of pneumonia patients Download PDF

Info

Publication number
CN111658703A
CN111658703A CN202010692365.0A CN202010692365A CN111658703A CN 111658703 A CN111658703 A CN 111658703A CN 202010692365 A CN202010692365 A CN 202010692365A CN 111658703 A CN111658703 A CN 111658703A
Authority
CN
China
Prior art keywords
parts
portions
patients
traditional chinese
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010692365.0A
Other languages
Chinese (zh)
Inventor
胡之纲
徐立然
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanfang Taiyao Biotechnology Ningbo Co ltd
Original Assignee
Hanfang Taiyao Biotechnology Ningbo Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanfang Taiyao Biotechnology Ningbo Co ltd filed Critical Hanfang Taiyao Biotechnology Ningbo Co ltd
Priority to CN202010692365.0A priority Critical patent/CN111658703A/en
Publication of CN111658703A publication Critical patent/CN111658703A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532—Agastache, e.g. giant hyssop
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for accelerating recovery of pneumonia patients, which comprises 58-62 parts of astragalus root, 13-16 parts of ginseng, 14-16 parts of cimicifuga foetida, 28-32 parts of rhizoma atractylodis, 27-31 parts of phellodendron, 8-11 parts of clove, 28-33 parts of wrinkled gianthyssop herb, 14-16 parts of cortex dictamni, 29-31 parts of dandelion, 28-32 parts of fructus forsythiae, 14-17 parts of dried orange peel and 8-11 parts of liquorice by weight, and the pharmacological action is based on three points: one, the virus invades, dampness stays and toxin destroys the body; lung qi deficiency and insecurity of defensive qi; the traditional Chinese medicine is proved to have the purposes of ascending and reaching vital qi, detoxifying and eliminating evil, and eliminating turbid pathogen with aromatics, thereby accelerating the recovery of patients through a large number of experiments and pharmacological compatibility verification.

Description

Traditional Chinese medicine for accelerating recovery of pneumonia patients
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine for accelerating recovery of pneumonia patients.
Background
Pneumonia refers to inflammation of the terminal airways, alveoli and lung interstitium, and may be caused by disease microorganisms, physicochemical factors, immune injury, allergy and drugs. Bacterial pneumonia is the most common pneumonia and is one of the most common infectious diseases, the pneumonia is easy to cause the phenomena of chill, high fever, difficulty in customers, chest pain, dyspnea, nausea, vomiting and the like, especially, a patient infected with new coronavirus can only be treated specially without a special medicine, the period is long, the diseases are easy to cause, and poor spirit, lassitude and hypodynamia, inappetence, sweating, poor sleep and the like generally exist in a large number of patients with yin turning to yang; pale tongue, white and greasy coating and weak pulse, which are usually recovered slowly by dietetic invigoration due to weak body, and the treatment course is longer and needs to be improved.
Disclosure of Invention
In order to solve the technical defects, the application document provides a traditional Chinese medicine for accelerating recovery of patients with pneumonia, which comprises, by weight, 58-62 parts of astragalus membranaceus, 13-16 parts of ginseng, 14-16 parts of rhizoma cimicifugae, 28-32 parts of rhizoma atractylodis, 27-31 parts of cortex phellodendri, 8-11 parts of clove, 28-33 parts of agastache rugosus, 14-16 parts of cortex dictamni, 29-31 parts of dandelion, 28-32 parts of fructus forsythiae, 14-17 parts of pericarpium citri reticulatae and 8-11 parts of liquorice.
The functions of the components are as follows: astragalus root: has effects in enhancing immunity, protecting liver, promoting urination, resisting aging, resisting stress, lowering blood pressure, and inhibiting bacteria. Can eliminate albuminuria caused by experimental nephritis, enhance myocardial contraction force, and regulate blood sugar content. Radix astragali can not only dilate coronary artery, improve myocardial blood supply, and enhance immunity, but also delay cell aging process.
Ginseng: the tonic is suitable for regulating blood pressure, restoring cardiac function, treating neurasthenia and asthenia, and has expectorant, stomach invigorating, diuretic, and exciting effects.
Cimicifugae foetidae: mainly has the efficacies of lifting hair, clearing heat and detoxicating and the like.
Rhizoma atractylodis: the rhizome is used as the spleen-activating herb, and has the actions of drying dampness, resolving turbidity and alleviating pain.
Phellodendron bark: bitter taste and cold nature. Clear heat and remove toxicity, purge fire and dry dampness. Can be used for treating acute bacillary dysentery, acute enteritis, acute icterohepatitis, and urinary system infection.
Clove: has the effects of warming the middle-jiao, lowering the adverse flow of qi, warming the kidney and tonifying yang.
Agastache rugosus: can be used for treating damp obstruction in middle warmer, abdominal distention, emesis, summer-heat dampness exterior syndrome, early stage of damp-warm syndrome, fever, listlessness, chest distress, cold-dampness, summer-heat, abdominal pain, emesis, diarrhea, nasosinusitis, and headache.
Cortex dictamni: clearing heat, eliminating dampness, dispelling pathogenic wind, and removing toxic substance, and can be used for treating damp-heat sore, yellow water dripping, eczema, rubella, scabies, tinea, moth cocoon, rheumatism, jaundice, and dark urine.
Dandelion: clear heat and remove toxicity, induce diuresis and dissipate nodulation. It can be used for treating acute mastitis, lymphadenitis, lymphoid tuberculosis, furunculosis, acute conjunctivitis, common cold with fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, and urinary tract infection.
Fructus forsythiae: has effects of clearing away internal heat.
Dried orange peel: can be used for treating chest and abdomen distention; can be used for treating damp retention in middle energizer, abdominal distention, loose stool, diarrhea, excessive phlegm, and cough; can be used for treating spleen deficiency, anorexia, dyspepsia, nausea, and emesis.
Licorice root: the functions are mainly used for clearing away heat and toxic material, eliminating phlegm and relieving cough, and treating abdominal cavity and the like.
The pharmacological action is based on three points: one, the virus invades, dampness stays and toxin destroys the body; lung qi deficiency and insecurity of defensive qi; spleen qi is deficient and fails to transport and transform. The traditional Chinese medicine is proved by a large number of experiments and pharmacological compatibility, and the prescription is obtained, and aims to promote vital qi to rise, detoxify and eliminate pathogenic factors, and eliminate dampness with aromatics, so that the recovery of patients is accelerated.
Compared with the prior art, the technical scheme of the invention has the beneficial effects that:
1. the traditional Chinese medicine composition adopts a pure traditional Chinese medicine preparation, has mild medicine properties, reasonably mixes the traditional Chinese medicine components, nourishes, stimulates the appetite, detoxifies, can effectively improve the physique of a pneumonia patient, accelerates the detoxification, and shortens the recovery period.
Detailed Description
The present invention will be further described with reference to the following specific examples.
Medicine preparation
The formula is as follows:
example 1
Comprises 58 parts of astragalus root, 13 parts of ginseng, 14 parts of cimicifuga foetida, 28 parts of rhizoma atractylodis, 27 parts of phellodendron, 8 parts of clove, 28 parts of wrinkled gianthyssop herb, 14 parts of cortex dictamni, 29 parts of dandelion, 28 parts of forsythia, 14 parts of dried orange peel and 8 parts of liquorice.
Example 2
Comprises 62 portions of astragalus root, 16 portions of ginseng, 16 portions of cimicifuga foetida, 32 portions of rhizoma atractylodis, 31 portions of phellodendron, 11 portions of clove, 33 portions of ageratum, 16 portions of cortex dictamni, 31 portions of dandelion, 32 portions of forsythia, 17 portions of dried orange peel and 11 portions of liquorice.
Example 3
Comprises 60 portions of astragalus root, 15 portions of ginseng, 15 portions of cimicifuga foetida, 30 portions of rhizoma atractylodis, 30 portions of phellodendron, 10 portions of clove, 30 portions of ageratum, 15 portions of cortex dictamni, 30 portions of dandelion, 30 portions of forsythia, 15 portions of dried orange peel and 10 portions of liquorice.
Example 4
Comprises 59 portions of astragalus root, 14 portions of ginseng, 16 portions of cimicifuga foetida, 31 portions of rhizoma atractylodis, 28 portions of phellodendron, 8 portions of clove, 28 portions of ageratum, 15 portions of cortex dictamni, 30 portions of dandelion, 30 portions of forsythia, 14 portions of dried orange peel and 10 portions of liquorice.
The manufacturing method comprises the following steps:
sieving the above raw materials mixture, pulverizing, mixing, granulating, grading, encapsulating, polishing, and packaging to obtain capsule preparation 10 g/bag.
Second, clinical practice
1. Selection of case criteria-compliance with symptoms: patients with common pneumonia (stable vital signs through clinical treatment) and patients with new coronary pneumonia (stable vital signs through clinical treatment or turning yin and restoring yang), and both patients have poor spirit, lassitude and hypodynamia, inappetence, sweating, poor sleep and the like; pale tongue with white and greasy coating and deficient pulse.
The patients with the above symptoms are treated by preparing the traditional Chinese medicine according to the above examples.
The treatment scheme comprises the following steps: the capsule granules prepared according to the above embodiment are taken three times a day in 10 g/bag for 3 days as 1 treatment course, and three treatment courses are continued.
3) Evaluation of therapeutic Effect
After one treatment course, 70 patients with common pneumonia have improved spirit, no hypodynamia phenomenon, good sleep quality, greatly increased appetite and no obvious improvement on other symptoms; after 2 treatment courses, the sweating and pulse deficiency of 82 patients are greatly improved; after 3 treatment courses, 91 patients recovered.
Among 12 patients with new coronary pneumonia, the 12 patients turn yin and recover yang after clinical treatment, the vital signs are stable, and after 1 treatment course, 8 patients have good mental state, improved hypodynamia, increased appetite and improved sleep; after 2 treatment courses, 9 patients have good mental state, no sense of weakness under normal conditions, greatly increased appetite, greatly improved sleep and reduced pulse deficiency; after 3 treatment courses, the symptoms of 11 patients were greatly improved and the patients were basically recovered to normal conditions.
No adverse reaction and toxic or side effect are found during the medication period, which indicates that the medication is safe and effective.
The above is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above-mentioned embodiments, and all technical solutions belonging to the idea of the present invention belong to the protection scope of the present invention. It should be noted that modifications and embellishments within the scope of the invention may occur to those skilled in the art without departing from the principle of the invention, and are considered to be within the scope of the invention.

Claims (5)

1. A traditional Chinese medicine for accelerating recovery of pneumonia patients is characterized in that: comprises 58-62 parts of astragalus root, 13-16 parts of ginseng, 14-16 parts of cimicifuga foetida, 28-32 parts of rhizoma atractylodis, 27-31 parts of phellodendron, 8-11 parts of clove, 28-33 parts of wrinkled gianthyssop herb, 14-16 parts of cortex dictamni, 29-31 parts of dandelion, 28-32 parts of forsythia, 14-17 parts of dried orange peel and 8-11 parts of liquorice.
2. The traditional Chinese medicine for accelerating recovery of patients with pneumonia according to claim 1, characterized in that: comprises 58 parts of astragalus root, 13 parts of ginseng, 14 parts of cimicifuga foetida, 28 parts of rhizoma atractylodis, 27 parts of phellodendron, 8 parts of clove, 28 parts of wrinkled gianthyssop herb, 14 parts of cortex dictamni, 29 parts of dandelion, 28 parts of forsythia, 14 parts of dried orange peel and 8 parts of liquorice.
3. The traditional Chinese medicine for accelerating recovery of patients with pneumonia according to claim 1, characterized in that: comprises 62 portions of astragalus root, 16 portions of ginseng, 16 portions of cimicifuga foetida, 32 portions of rhizoma atractylodis, 31 portions of phellodendron, 11 portions of clove, 33 portions of ageratum, 16 portions of cortex dictamni, 31 portions of dandelion, 32 portions of forsythia, 17 portions of dried orange peel and 11 portions of liquorice.
4. The traditional Chinese medicine for accelerating recovery of patients with pneumonia according to claim 1, characterized in that: comprises 60 portions of astragalus root, 15 portions of ginseng, 15 portions of cimicifuga foetida, 30 portions of rhizoma atractylodis, 30 portions of phellodendron, 10 portions of clove, 30 portions of ageratum, 15 portions of cortex dictamni, 30 portions of dandelion, 30 portions of forsythia, 15 portions of dried orange peel and 10 portions of liquorice.
5. The traditional Chinese medicine for accelerating recovery of patients with pneumonia according to claim 1, characterized in that: comprises 59 portions of astragalus root, 14 portions of ginseng, 16 portions of cimicifuga foetida, 31 portions of rhizoma atractylodis, 28 portions of phellodendron, 8 portions of clove, 28 portions of ageratum, 15 portions of cortex dictamni, 30 portions of dandelion, 30 portions of forsythia, 14 portions of dried orange peel and 10 portions of liquorice.
CN202010692365.0A 2020-07-17 2020-07-17 Traditional Chinese medicine for accelerating recovery of pneumonia patients Pending CN111658703A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010692365.0A CN111658703A (en) 2020-07-17 2020-07-17 Traditional Chinese medicine for accelerating recovery of pneumonia patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010692365.0A CN111658703A (en) 2020-07-17 2020-07-17 Traditional Chinese medicine for accelerating recovery of pneumonia patients

Publications (1)

Publication Number Publication Date
CN111658703A true CN111658703A (en) 2020-09-15

Family

ID=72392985

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010692365.0A Pending CN111658703A (en) 2020-07-17 2020-07-17 Traditional Chinese medicine for accelerating recovery of pneumonia patients

Country Status (1)

Country Link
CN (1) CN111658703A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919990A (en) * 2022-12-28 2023-04-07 纳元(宁波)生物医药科技有限公司 Traditional Chinese medicine formula for benefiting lung

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435162A (en) * 2014-10-27 2015-03-25 景东旭 Oral traditional Chinese medicine preparation for treating viral pneumonia
CN111388615A (en) * 2020-04-10 2020-07-10 华中科技大学同济医学院附属协和医院 Traditional Chinese medicine mixture for preventing and treating pneumonia and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435162A (en) * 2014-10-27 2015-03-25 景东旭 Oral traditional Chinese medicine preparation for treating viral pneumonia
CN111388615A (en) * 2020-04-10 2020-07-10 华中科技大学同济医学院附属协和医院 Traditional Chinese medicine mixture for preventing and treating pneumonia and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
诸晶等: "林求诚主任应用"加味玉屏风散"经验拾萃", 《当代医学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115919990A (en) * 2022-12-28 2023-04-07 纳元(宁波)生物医药科技有限公司 Traditional Chinese medicine formula for benefiting lung

Similar Documents

Publication Publication Date Title
CN102836290A (en) Chinese herbal tea for preventing and treating flu
CN101007140A (en) A proprietary Chinese medicine for treating chronic pharyngitis
CN103301267B (en) Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof
CN111658703A (en) Traditional Chinese medicine for accelerating recovery of pneumonia patients
CN104352933A (en) Wind-dispelling and dampness-eliminating traditional Chinese medicine containing golden buckwheat rhizomes
CN113499407A (en) Traditional Chinese medicine mixture for treating helicobacter pylori and preparation method thereof
CN102366576A (en) Chinese herbal medicine preparation used for treating rheumatic arthralgia
CN111991528A (en) A medicine for treating burn and preparation method thereof
CN101234139A (en) Proprietary Chinese medicine for curing common cold and preparation thereof
CN104826025A (en) Traditional Chinese medicine preparation for treating hepatapostema and preparation method thereof
CN103690715A (en) Traditional Chinese medicine for treating ischemic colitis
CN103705614B (en) Traditional Chinese medicine for treating herpes zoster
CN101745081A (en) Compound cattail pollen for viral hepatitis
CN105012775A (en) Traditional Chinese medicine for treating acute mastitis
CN104689038A (en) Traditional Chinese medicine cough syrup for treating pediatric dyspneic cough and preparation method thereof
CN104435162A (en) Oral traditional Chinese medicine preparation for treating viral pneumonia
CN117180372A (en) Traditional Chinese medicine for accelerating recovery of pneumonia patient
CN105412511A (en) Medicine composition for treating prostatitis
CN105055758A (en) Traditional Chinese medicine for treating stomatitis
CN103656220A (en) Traditional Chinese medicine for treating spleen-kidney-yang-deficiency type chronic enteritis
CN104257804A (en) Yao medicine preparation for treating acquired immune deficiency syndrome and preparation method of Yao medicine preparation
CN103830611B (en) A kind of Chinese medicine for the treatment of measles complicated by pneumonia pattern of syndrome pneumonia
CN117100829A (en) Traditional Chinese medicine preparation for treating novel coronavirus infection and preparation method thereof
CN117159664A (en) Traditional Chinese medicine granule formula for treating gastric ulcer and duodenal ulcer and preparation method thereof
CN104352872A (en) Traditional Chinese medicine for treating pulmonary asthenia due to deficiency heat

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200915